Skip to main content
. Author manuscript; available in PMC: 2020 May 16.
Published in final edited form as: J Leukoc Biol. 2020 Feb 4;107(4):663–671. doi: 10.1002/JLB.3A0120-379RR

FIGURE 4. IL-33 activates p38 MAPK in human NK cells.

FIGURE 4

Human NK cells were left untreated (UT) or incubated with IL-12 or IL-33 (doses in ng/ml indicated on right) for 5–30 min prior to phosphoflow measurement of intracellular (A) phospho-p38 MAPK, (B) phospho-ATF2 levels. Representative histogram plots are shown (1 of 5 similar experiments with cells from different subjects), along with graphs of median of fluorescence intensity (MFI, each dot represents results obtained from an independent donor). Multiple comparisons of ordinary 1-way ANOVA were used to compare columns with P < 0.1 shown